173
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Dynamic features of apo and bound HIV-Nef protein reveal the anti-HIV dimerization inhibition mechanism

, &
Pages 346-356 | Received 19 Sep 2014, Accepted 02 Nov 2014, Published online: 19 Nov 2014

References

  • Rambaut A, Posada D, Crandall KA, Holmes EC. The causes and consequences of HIV evolution. Nat Rev Genet 2004;5:52–61
  • Xu Y, Liu H, Niu CY, et al. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor. Bioorg Med Chem 2004;12:6193–208
  • Soliman MES. A hybrid structure/pharmacophore-based virtual screening approach to design potential leads: a computer-aided design of South African HIV-1 subtype C protease inhibitors. Drug Dev Res 2013;74:283–95
  • Johnson BC, Pauly GT, Rai G, et al. A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology 2012;9:99
  • Morah EU. Are people aware of their HIV-positive status responsible for driving the epidemic in SubSaharan Africa? The case of Malawi. Development Policy Review 2007;25:215–42
  • Bhakat S, Martin AJM, Soliman MES. An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine. Mol Biosyst 2014;10:2215–28
  • Sarafianos SG, Das K, Hughes SH, Arnold E. Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr Opin Struct Biol 2004;14:716–30
  • Das SR, Jameel S. Biology of the HIV Nef protein. Indian J Med Res 2005;121:315–32
  • Emert-Sedlak LA, Narute P, Shu ST, et al. Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity. Chem Biol 2013;20:82–91
  • Breuer S, Schievink SI, Schulte A, et al. Molecular design, functional characterization and structural basis of a protein inhibitor against the HIV-1 pathogenicity factor Nef. PLos One 2011;6:e20033
  • Lindorff-Larsen K, Piana S, Dror RO, Shaw DE. How fast-folding proteins fold. Science 2011;334:517–20
  • Garcia AE. Molecular dynamics simulations of protein folding. Methods Mol Biol (Clifton, N.J.) 2008;413:315–30
  • Gsponer J, Caflisch A. Molecular dynamics simulations of protein folding from the transition state. Proc Natl Acad Sci USA 2002;99:6719–24
  • Swope WC, Pitera JW, Suits F, et al. Describing protein folding kinetics by molecular dynamics simulations. 2. Example applications to alanine dipeptide and beta-hairpin peptide. J Phys Chem B 2004;108:6582–94
  • Durrant JD, McCammon JA. Molecular dynamics simulations and drug discovery. BMC Biol 2011;9:71–79
  • Wan H, Hu J-p, Tian X-h, Chang S. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d. Phys Chem Chem Phys 2013;15:1241–51
  • Karubiu W, Bhakat S, Soliman MS. Compensatory role of double mutation N348I/M184V on nevirapine binding landscape: insight from molecular dynamics simulation. Protein J 2014;33:432–446
  • Ruiz-Pernía JJ, Silla E, Tuñón I. Enzymatic effects on reactant and transition states. The case of chalcone isomerase. J Am Chem Soc 2007;129:9117–24
  • Ruiz-Pernía JJ, Silla E, Tuñón I, Martí S. Hybrid quantum mechanics/molecular mechanics simulations with two-dimensional interpolated corrections: application to enzymatic processes. J Phys Chem B 2006;110:17663–70
  • Thorpe IF, Brooks III CL. Conformational substates modulate hydride transfer in dihydrofolate reductase. J Am Chem Soc 2005;127:12997–3006
  • Zhang Y, Kua J, McCammon JA. Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study. J Am Chem Soc 2002;124:10572–7
  • Bruice TC, Bruice PY. Covalent intermediates and enzyme proficiency. J Am Chem Soc 2005;127:12478–9
  • Benkovic SJ, Hammes-Schiffer S. A perspective on enzyme catalysis. Science 2003;301:1196–202
  • Warshel A. Energetics of enzyme catalysis. Proc Natl Acad Sci 1978;75:5250–4
  • Borodin O, Smith GD. Molecular dynamics simulations of poly(ethylene oxide)/LiI melts. 2. Dynamic properties. Macromolecules 2000;33:2273–83
  • Falconi M, Biocca S, Novelli G, Desideri A. Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant. BMC Struct Biol 2007;7:73–83
  • Lee CH, Saksela K, Mirza UA, et al. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 1996;85:931–42
  • Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimera - a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12
  • Moonsamy S, Soliman MES. Dual acting HIV inhibitors: integrated rational in silico design strategy. Med Chem Res 2014;23:682–9
  • Moonsamy S, Soliman MES. Computer-aided perspective for the design of flexible HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs): de-novo drug design, virtual screening and molecular dynamics simulations. Lett Drug Design Discov 2014;11:513–24
  • Trott O, Olson AJ. Software news and update Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–61
  • Lau CD, Levesque MJ, Chien S, et al. ViewDock TDW: high-throughput visualization of virtual screening results. Bioinformatics 2010;26:1915–17
  • Goetz AW, Williamson MJ, Xu D, et al. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J Chem Theory Comput 2012;8:1542–55
  • Wang JM, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem 2004;25:1157–74
  • Lindorff-Larsen K, Piana S, Palmo K, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins: Struct Funct Bioinf 2010;78:1950–8
  • Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparsion of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926–35
  • Harvey MJ, De Fabritiis G. An implementation of the smooth particle mesh ewald method on gpu hardware. J Chem Theory Comput 2009;5:2371–7
  • Roe DR, Cheatham III TE. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 2013;9:3084–95
  • Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Molec Graph Model 1996;14:33–8
  • Bakan A, Meireles LM, Bahar I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 2011;27:1575–7
  • Iyer PC, Zhao J, Emert-Sedlak LA, et al. Synthesis and structure-activity analysis of diphenylpyrazolodiazene inhibitors of the HIV-1 Nef virulence factor. Bioorg Med Chem Lett 2014;24:1702–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.